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Anurans are declining worldwide because of the spread of Batachochytrium 
dendrobatidis (Bd), the fungus that causes chytridiomycosis. However, some frogs are 
resistant to this disease, and understanding why may be critical to saving those that are 
susceptible. In Peru, Gastrotheca excubitor is resistant to chytridiomycosis while 
Gastrotheca nebulanastes is susceptible. Two anuran skin defenses, symbiotic bacteria 
and antimicrobial peptides (AMPs), have demonstrated the ability to inhibit Bd in vitro 
when isolated from certain frogs. We tested if these defenses can explain the difference 
in susceptibility between the two Gastrotheca species. The cutaneous bacteria and 
AMPs of both species were collected, tested for their abilities to inhibit the growth of Bd, 
and analyzed for their compositions. Results indicate that 34%of the strains of skin 
bacteria from G. excubitor were able to inhibit the growth of Bd whereas only 10% 
isolated from G. nebulanastes were effective. Gastrotheca excubitor also has stronger 
anti-Bd skin bacteria. Neither frog species has peptide mixtures capable of completely 
inhibiting Bd, and overall species did not differ in the anti-Bd abilities of their peptides. 
These results suggest that the chytridiomycosis resistance experienced by G. excubitor 
may be attributed to its skin bacteria. 
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CHAPTER 1 
NATURAL ANURAN DEFENSES AGAINST CHYTRIDIOMYCOSIS: THE ROLES OF 
ANTIMICROBIAL PEPTIDES AND CUTANEOUS BACTERIA 
INTRODUCTION: 
Amphibians are currently one of the most endangered vertebrate groups. 
Approximately one third of all amphibian species are listed as threatened by the IUCN, 
and in the past several decades there have been over 100 species extinctions and 
thousands of populations have experienced significant declines (Stuart et al., 2004). 
Many factors are contributing to amphibian declines including habitat loss, climate 
change, and the spread of infectious diseases (Fisher and Shaffer, 1996, Davidson et 
al., 2001, Marsh and Trenham, 2001, Pounds et al., 1997, Pounds et al., 1999, 
Kiesecker et al., 2001, Carey and Alexander, 2003, Daszak et al., 2003). One of these 
infectious diseases, chytridiomycosis, may be the most significant contributor to 
amphibian declines. 
 Chytridiomycosis is caused by the fungus Batrachochytrium dendrobatidis (Bd). 
It is an emerging infectious disease that has been linked to the extinctions and 
extirpations of numerous amphibian species world-wide (Daszak and Berger, 1999, 
Berger et al., 1998b, Skerratt et al., 2007, Fisher et al., 2009). Bd was first described 
when the fungus was isolated from dead and dying frogs from Australia and Central 
America (Berger et al. 1998). Effective treatment strategies for chytridiomycosis are 
critical because it is unlikely that Bd will be eradicated form the environment. 
Chytridiomycosis is currently treated by various anti-fungal drugs or by heat therapy. 
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While both strategies are effective, none of these have any applications for frogs in situ. 
A strategy that can protect the remaining vulnerable frogs may allow for populations to 
persist in their natural environment.  
Because some frog species are resistant to Bd, their natural defenses are being 
studied for their abilities to inhibit fungal growth. Two of these defenses, antimicrobial 
peptides (AMPs) and cutaneous skin bacteria, show promise. AMPs and cutaneous 
bacteria from many frog species have already demonstrated anti-Bd capabilities. 
Perhaps one or both of these defenses could be applied to or amplified in susceptible 
frogs as an enriching defense against Bd.     
 
ROLE OF BATRACHOCHYTRIUM DENDROBATIDIS IN AMPHIBIAN DECLINES: 
Bd infects its amphibian host with motile zoospores in aqueous environments. 
The zoospores infect keratinized mouthparts on tadpoles or keratinized epidermal skin 
cells on adults. Following infection, the fungus grows as a thallus and eventually 
produces reproductive structures, the zoosporangia, where new zoospores are 
produced and released (Berger et al., 2005a, Kilpatrick et al., 2010). Infection causes 
reduced electrolyte transport, impairing osmoregulation and ultimately causing death by 
asystolic cardiac arrest  (Voyles et al., 2009). The fungus has been shown to spread 
geographically very quickly (Vredenburg et al., 2010). Once arriving in a new location, 
Bd can quickly reduce the population size of the naive frog species (Lips et al., 2006). 
Bd has had a global impact on amphibian populations. To date significant declines 
attributed to Bd have occurred in Australia, Panama, Costa Rica, Peru, and the United 
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States (Pounds et al., 1997, Berger et al., 1998b, Lips et al., 2008, Catenazzi et al., 
2011, Vredenburg et al., 2010, Vredenburg et al., 2011).  
 
AMPHIBIAN IMMUNE SYSTEM: 
To fight off disease, frogs possess both innate and adaptive immune systems, as 
well as products metabolized by symbiotic skin bacteria (Harris et al., 2006, Harris et al., 
2009a, Brucker et al., 2008). The innate immune system is non-specific and acts quickly 
upon infection by a pathogen. This system includes phagocytic cells, lysozymes, and 
antimicrobial peptides (AMPs). The adaptive immune system includes antigen-specific T 
and B lymphocytes that are created by previous exposure to their specified pathogen. 
The adaptive immune system does play some role in defense against chytridiomycosis 
as reduced lymphocyte numbers results in increased intensity of infection (Ramsey et 
al., 2010). However, Bd has been shown to inhibit lymphocyte production and induce 
apoptosis, which interferes with the development of an effective cell-mediated defense 
(Fites et al., 2013a, Fites et al., 2013b). Since Bd infects the keratinized epidermal cells 
of the skin, a frog’s cutaneous defenses are the first line of defense against 
chytridiomycosis (Rollins-Smith et al., 2002b).  Therefore, these defenses, which include 
AMPs and cutaneous bacteria, may be very important in providing protection against 
chytridiomycosis.  
 
ANTIMICROBIAL PEPTIDES: 
AMPs are synthesized in granular glands located on the frog’s skin where they 
are stored as preproproteins (Bovbjerg, 1963, Mills and Prum, 1984, Rollins-Smith et al., 
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2005). Activation of the sympathetic nervous system stimulates certain nerve receptors 
in the muscle tissue surrounding these glands (Benson and Hadley, 1969, Dockray and 
Hopkins, 1975, Sjöberg and Flock, 1976, Holmes and Balls, 1978), and the 
preproprotein is cleaved to release an activated AMP (Resnick et al., 1991, Amiche et 
al., 1999, Bowie et al., 1999). The activated peptide is secreted from the granular gland 
and combined with mucous secreted from the frog’s cutaneous mucous glands, coating 
the skin (Schumacher et al., 1994, Rollins-Smith et al., 2011, Gammill et al., 2012). Most 
AMPs are cationic and characterized by hydrophobic regions (Nicolas and Mor, 1995, 
Simmaco et al., 1998, Zasloff, 2002). They are therefore able to bind to negatively-
charged regions on their target’s lipid membranes (Nicolas and Mor, 1995) and lyse their 
target cells by either embedding into the membrane’s matrix or by creating disruptive 
pores that leak intracellular material (Amiche et al., 1999, Conlon et al., 2004b, 
Pasupuleti et al., 2012).  
Early research on frog AMPs focused on refining the methodology of collecting 
and isolating them and identifying individual peptides (Dockray and Hopkins, 1975, Tyler 
et al., 1992, Bowie et al., 1999). These isolates were then assayed against pathogens, 
revealing that many peptides were effective against bacteria, fungi, protozoa, and 
viruses (Nicolas and Mor, 1995, Simmaco et al., 1998, Conlon et al., 2004a, Apponyi et 
al., 2004, Zasloff, 2002, Rinaldi, 2002). Research then shifted to a conservation 
approach in response to amphibian declines. In vitro assays were developed to test frog 
peptides for activity against pathogens like Bd (Rollins-Smith et al., 2002a, Rollins-Smith 
et al., 2002b, Rollins-Smith et al., 2002c). Most of the peptides used in this early testing 
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demonstrated anti-Bd activity, including those isolated from a declining frog susceptible 
to Bd, Rana tarahuamara (Rollins-Smith et al., 2002c).   
Drastic frog population declines in Australia led to extensive research on the 
AMPs of Australian frogs. The peptide compositions of many of these frog species are 
well documented (Bowie et al., 1999), and when assayed against Bd most of these 
peptides inhibited growth regardless of source host susceptibility, although AMP 
effectiveness did decrease with host susceptibility (Woodhams et al., 2007a). The AMPs 
of the declining North American frog Rana muscosa have also been assayed for activity 
against Bd, revealing that these frogs have a rich repertoire of anti-Bd AMPs despite 
being susceptible (Woodhams et al., 2007b). Therefore, the presence of anti-Bd AMPs 
does not always correlate with resistance to chytridiomycosis. This relationship has also 
been demonstrated in other frogs from different families distributed worldwide, including: 
Alytes obstetricans in Europe (Bosch and Rincón, 2008), Silurana tropicalis in Africa 
(Parker et al., 2002), and Hylomantis lemur in South America (Conlon et al., 2007b). 
 
CUTANEOUS BACTERIA: 
The diverse community of bacteria that naturally occurs on frogs’ skins are 
another important component to their immune systems. These bacteria are probably 
established on the skin when frogs are young (Fierer et al., 2012). Species that exhibit 
parental care may transmit bacteria vertically (Walke et al., 2011). Symbionts are also 
probably transmitted horizontally during mating and hibernating aggregations or acquired 
from the environment (Muletz et al., 2012). It is suggested that within an amphibian 
community, cutaneous microbe composition vary more among species than across 
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space (McKenzie et al., 2012), indicating some sort of genetic regulation of symbiont 
community structure. This microbial regulation may be controlled by the frog’s immune 
system, such as AMPs (Fierer et al., 2012); however, the establishment and 
composition of skin bacteria most likely depends on complex interactions among 
microbes and with the host’s mucosome (Scheuring et al., 2012). There may also be 
correlations between a frog’s diet and cutaneous microbe species richness, abundance, 
and community structure. For example, groups of captive Agalychnis callidryas fed diets 
varying in carotenoid composition/abundance differed in the skin microbes that they 
harbored (Antwis et al., 2014). 
While serving a variety of functions, some of these bacteria contribute to their 
host’s immunity. They may destroy pathogens by excreting metabolites, inhibit pathogen 
colonization by competition, or enhance other components of the host’s innate immune 
system (Harris et al., 2006, Brucker et al., 2008, Flechas et al., 2012). As with AMPs, 
cutaneous bacteria are currently being sampled and assayed for their effectiveness 
against Bd (Harris et al., 2006, Flechas et al., 2012). Cutaneous bacteria have been 
sampled from the skins of many frog species, cultured, and assayed in vitro for their 
abilities to inhibit the growth of Bd. These assays typically involve growing a fungal 
“lawn" of Bd across a petri dish and streaking the query bacteria on one side and a 
negative control bacteria on the other side (Flechas et al., 2012, Brucker et al., 2008, 
Harris et al., 2009a). Anti-fungal activity is measured by clear zones of inhibition around 
the query bacteria. However, the design of these assays allow for only semi-quantitative 
measurements of anti-Bd activity and it is difficult to control for the amount of Bd 
zoospores tested (Bell et al., 2013). To mitigate these limitations a new co-culture assay 
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has been developed with a design similar to the AMP-Bd inhibition assay developed by 
Rollins-Smith (2002a) (Bell et al., 2013). 
 In the United States, the bacterium Janthinobacterium lividum occurs naturally on 
many native amphibian species and produces the anti-fungal metabolite violacein 
(Brucker et al., 2008). It has been demonstrated that this metabolite is capable of 
inhibiting the growth of Bd in vitro (Brucker et al., 2008, Harris et al., 2009a). The 
capabilities of J. lividum to protect amphibians from Bd has been studied extensively. 
This bacterium naturally occurs on the salamander Plethodon cinereus, and when these 
salamanders were experimentally augmented with J. lividum they had increased levels 
of violacein and were more likely to survive experimental infection with Bd (Becker et al., 
2009).  Additionally, experimentally removing J. lividum form the skins of P. cinereus 
decreased an individual’s likelihood to survive experimental infection with Bd (Becker 
and Harris, 2010).  
Frogs in the mountain yellow legged frog complex also naturally harbor J. lividum.  
Some of these frogs have been experiencing dramatic population declines due to 
chytridiomycosis (Briggs et al., 2005, Rachowicz et al., 2006). However, it is suggested 
that among and within mountain yellow legged frog species, populations with larger 
quantities of anti-Bd bacteria do not experience declines (Woodhams et al., 2007a, Lam 
et al., 2010). For example, more individuals from non-declining populations of Rana 
sierrae may harbor more anti-Bd bacteria than individuals in declining populations of 
Rana muscosa (Woodhams et al., 2007a). Additionally, a separate population of R. 
muscosa that was found to be composed of a high number of individuals with anti-Bd 
bacteria was not in decline (Lam et al., 2010). J. lividum was common among the anti-
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Bd bacteria found in these studies. This bacterium has been demonstrated to protect 
susceptible R. muscosa from Bd infections in vivo because individuals exposed to J. 
lividum prior to infection with Bd survived whereas those that were not inoculated with J. 
lividum did not (Harris et al., 2009a). An emergency inoculation with J. lividum of a 
declining population of R. muscosa in the wild was executed, and this population 
continues to persist despite the presence of Bd (Vredenburg et al., 2011).    
 
AMPS, CUTANEOUS BACTERIA, AND CONSERVATION: 
The results accrued from research involving frog AMPs and cutaneous bacteria 
and their abilities to inhibit the growth of Bd have inspired potential conservation 
strategies. The most feasible of these strategies may be the application of anti-Bd 
bacteria as probiotics by bioaugmentation therapy (Bletz et al., 2013). This strategy 
involves amplifying the presence of naturally occurring beneficial symbionts to better 
protect the host. Bioaugmentation with the anti-Bd bacterium J. lividum has already been 
successful in vivo with both the salamander P. cinereus (in captivity) and the frog R. 
muscosa (Harris et al., 2009a, Muletz et al., 2012, Vredenburg et al., 2011).  
Perhaps bioaugmentation therapy could also be used to save wild populations of 
susceptible frogs, but the transition from laboratory experiments to wild populations will 
come with challenges. There has been little research on applying this strategy in natural 
systems (Bletz et al., 2013), and abiotic factors will certainly influence the success of a 
probiotic when applied in situ. For example, mineral composition in the soil may 
influence the efficacy of bioaugmentation for plant crops in situ (Haas and Defago, 
2005). For frogs, it is unrealistic that every individual in a threatened population could be 
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collected and treated with a probiotic. Fortunately, vertical and horizontal transfer would 
help propagate the beneficial bacterium throughout a population (Walke et al., 2011, 
Muletz et al., 2012). Also, the results from the extensive work done with the mountain 
yellow legged frogs suggest that herd immunity, which occurs when a pathogen’s effects 
are inhibited by a high proportion of immune hosts, may prevent Bd outbreaks 
(Woodhams et al., 2007a, Lam et al., 2010). There is evidence that bioaugmentation 
can occur via environmental vectors such as soil, which gives hope that this strategy 
could be possible to implement without the need to catch frogs (Muletz et al., 2012).  
One important limitation to bioaugmentation is that the bacterium used must 
naturally occur on the host, and, depending on how it will be applied, in the environment. 
Failed attempts have occurred when trying to use bacteria from other hosts. For 
example, J. lividum could not be inoculated on the harlequin toad Atelopus zeteki 
(Becker et al., 2011) from Panama, where J. lividum has not been reported. Similarly, 
skin microbes (in the form of whole skin washings) could not be inoculated from the 
glass frog Espadarana prosoblepon onto the rocket frog Colostethus panamansis (Küng 
et al., 2014). Also, some anti-Bd bacteria fail to establish on frogs’ skins despite being 
generously applied (Woodhams et al., 2012b, Küng et al., 2014). It has been proposed 
that potential probiotics pass rigorous criteria testing before being considered for 
bioaugmentation (Bletz et al., 2013).   
The applications of anti-Bd AMPs towards conservation are less tangible given 
the current research. In fact, there have been almost no attempts to apply what is known 
about AMPs and their abilities to inhibit Bd towards protecting live frogs. In an un-
successful attempt, anti-Bd AMPs from the resistant frog Pelophylax esculentens were 
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applied to the susceptible toads Bufo bufo, but failed to protect toads from Bd infection 
(Woodhams et al., 2012b).  
Anti-Bd AMPs may not be successful when applied as a therapeutic agent, but, if 
AMP expression is heritable, their presence within a population could be amplified via 
selective breeding. There are captive reassurance colonies of Panamanian frog species 
whose natural populations have declined because of Bd. These frogs would be ideal 
candidates for a selective breeding strategy because the goal of the breeding program is 
to release animals that will repopulate wild areas where Bd is present. 
 It has also been suggested that AMPs could be used as predictors of a species’ 
susceptibility to Bd. The lack of anti-Bd AMPs was shown to correlate with declining 
populations in Bd afflicted Panamanian frog communities, suggesting that AMP profiles 
could be used as an indicator of susceptibility (Woodhams et al., 2006c). However, 
there are many susceptible species that have been found to produce AMPs in quantities 
sufficient enough to protect them from Bd infection (Parker et al., 2002, Rollins-Smith et 
al., 2002c, Woodhams et al., 2007a, Conlon et al., 2007a, Bosch and Rincón, 2008, 
Conlon et al., 2007b). These findings suggest that this defense alone is not capable of 
providing protection. 
 
FUTURE RESEARCH: 
The stronger correlation between chytridiomycosis resistance and anti-Bd skin 
microbes compared to AMPs provides evidence that bacteria may play a more important 
role in protecting frogs (Conlon et al., 2007b). It is even hypothesized that the reduction 
of AMP expression in some species is selected for to accommodate beneficial bacteria 
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(Conlon, 2011). It is also possible that the growth of skin microbes is regulated by AMPs 
(Küng et al., 2014) or that skin microbes enhance or mute the effects of AMPs; either 
way both defenses are likely engaged in a complex relationship. A combination of AMPs 
and a single bacterial metabolite (both from R. muscosa and both previously known to 
inhibit the growth of Bd individually) was more efficient at inhibiting the growth of Bd in 
vitro than either defense was alone (Myers et al., 2012). However, these laboratory 
assays do not represent the natural balance of AMPs and skin bacteria because only a 
bacterial metabolite was used.  
Regardless, the relationship between AMPs and skin bacteria should not be 
overlooked and future research should focus on untangling this complex relationship. 
Rarely are the capabilities of both defenses analyzed within a particular frog species or 
between species that differ in susceptibility to chytridiomycosis. In one example where 
both were assayed, the resistant R. sierrae harbored more anti-Bd bacteria than the 
susceptible R. muscosa, but the abilities of their AMPs to inhibit the growth of Bd did not 
differ (Woodhams et al., 2007a). There are methods to independently remove each of 
these defenses from a frog, so future research should focus on manipulating each 
defense’s presence while conducting susceptibility trials. 
 A large database consisting of the anti-Bd capabilities of susceptible and 
resistant species’ AMPs and bacteria could support a meta-analysis that would help 
elucidate which defense is most important. This information would be even more useful 
if resolved to the population level, as different populations of the same species can vary 
in their compositions of AMPs and bacteria (Lam et al., 2010, Woodhams et al., 2010b, 
Holden et al., 2015).  
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When searching for mitigation strategies it is easy to focus only on the effect that 
the defense has on a pathogen and ignore the effect that a pathogen may have on a 
defense. Bd has been shown to impair the adaptive immune system in frogs (Fites et al., 
2013b), and therefore could also impair their innate immune system. Recent evidence, 
from the laboratory and the field, suggests that Bd infection load can influence 
cutaneous bacteria compositions on R. sierrae by promoting the growth of certain 
bacterial taxa and inhibiting the growth of others (Jani and Briggs, 2014). Of the bacteria 
whose abundances were negatively correlated with Bd load, several belonged to genera 
that are known for their anti-Bd capabilities. However, a previous study examining the 
cutaneous bacteria of R. sierrae demonstrated that no strains belonging to these genera 
were capable of inhibiting Bd (Roth et al., 2013).  
Still, this research provides evidence that at least some bacterial species 
belonging to these beneficial genera are sensitive to Bd, and that the impact of Bd 
infection on a frog’s skin bacteria should not be overlooked. Similar laboratory and field 
studies should be conducted with other frog species whose compositions of anti-Bd and 
non-anti-Bd bacteria are known to determine how Bd infection load influences these 
compositions. Cutaneous bacteria can also be sampled and assayed against Bd before 
and after experimental infection of the host to determine if anti-Bd or non-anti-Bd 
bacteria change in response to infection. It would also be important to determine the 
mechanism that drives any observed changes in the bacterial community due to 
pathogen infection. These mechanisms could be direct (i.e. microbial composition) or 
indirect (i.e. a result of host behavior in response to infection). It is equally as important 
to examine the effects that Bd load can have on AMPs, although the natural brevity of 
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AMPs existence on the skin (approximately 2 hours [(Pask et al., 2012)]) may 
overshadow any observable effects.    
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CHAPTER 2 
THE IDENTIFICATION OF ANTI-BATRACHOCHYTRIUM DENDROBATIDIS SKIN 
BACTERIA IN PERUVIAN MARSUPIAL FROGS 
INTRODUCTION 
The skin is arguably an amphibian’s most important organ. This integument is 
responsible for most of the animal’s respiration and osmoregulation. With form matching 
function, amphibian skin has a permeable design that facilitates diffusion and osmosis. 
Unfortunately this sensitive membrane also allows easy access for infectious pathogens 
so cutaneous defenses are especially important for amphibians. One particular 
pathogen, the chytrid fungus Batrachochytrium dendrobatidis (Bd) (Longcore et al., 
1999), invades amphibian skin with motile zoospores, which encyst and proliferate in 
keratinized dermal tissue (Berger et al., 2005a, Kilpatrick et al., 2010). Eventually, the 
functionality of the integument is interrupted with the onset of the disease 
chytridiomycosis (Berger et al., 2005b). This pathogen is of particular conservation 
concern because of its recent global spread and lethal effects (Stuart et al., 2004). 
Understanding the role of skin defenses in infection may lead to the development of 
novel mitigation strategies against Bd.    
Amphibian skin is coated with a mucous consisting of a micro-environment, or 
mucosome, patrolled by components of both their adaptive and innate immune systems 
(Rollins-Smith et al., 2005). Protection is also provided by symbiotic bacteria (Harris et 
al., 2006). The bacteria that inhabit amphibian skin are likely established at a young age 
through environmental transmission from soil and water, although any sharing of refugia 
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is also likely to be an inter-individual source of inoculation, and for species with paternal 
care vertical transmission is probable (Walke et al. 2011, Fierer et al. 2012, Muletz et al. 
2012). Amphibian skin often has a diverse microbial community (Jani and Briggs, 2014). 
Compositions are typically species-specific but can vary among populations within a 
species that is distributed over a wide geographic range (McKenzie et al., 2012, Lam et 
al., 2010). Some of these bacteria protect their hosts by secreting metabolites to destroy 
invading pathogens (Brucker et al., 2008) and may also outcompete pathogens for 
space on the skin (Belden and Harris, 2007).  
Certain bacteria isolated from the skin of amphibians that are resistant to 
chytridiomycosis (henceforth, anti-Bd bacteria) have demonstrated the ability to inhibit 
the growth of Bd in in vitro co-culture assays (Flechas et al., 2012, Harris et al., 2006, 
Park et al., 2014). Metabolites isolated from cutaneous bacteria can also inhibit the 
growth of Bd alone (Loudon et al., 2014, Brucker et al., 2008), and it is suggested that 
zoospores actually avoid these metabolites through chemotaxis (Lam et al., 2011). 
Salamanders known to resist Bd infection experienced symptoms indicative of 
chytridiomycosis in experimental removals of anti-Bd bacteria (Becker and Harris, 2010). 
Additionally, the experimental addition of anti-Bd bacteria to susceptible amphibian 
species has ameliorated the effects of chytridiomycosis (Becker et al., 2009, Harris et 
al., 2009a, Harris et al., 2009b), suggesting that bioaugmentation therapy with probiotics 
may be a prophylactic strategy.  
The inhabitants of an amphibian’s skin appear to be highly regulated (Belden and 
Harris, 2007). A protocol to select anti-Bd bacteria for bioaugmentation suggests using 
bacteria already known to naturally inhabit the particular host species’ skin (Bletz et al., 
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2013), as not doing so has resulted in unsuccessful inoculation attempts (Becker et al., 
2011) and could introduce bacteria that disrupt the natural bacterial communities. 
Therefore, the natural microbiome must be examined for any susceptible species 
intended to be treated by probiotics, requiring sampling across a diverse taxa. There is 
currently a database of bacterial strains known to inhibit Bd which includes their 
probable identities and their hosts (Woodhams et al., 2015). As the size of this database 
increases, the number of frog species it could help protect may also increase. 
Although symbiotic bacteria are just one of many components of an amphibian’s 
defensive mechanisms against pathogens, they are of particular importance for 
providing protection against Bd. Zoospores, the infectious life stage of Bd, must first 
penetrate an amphibian’s skin to infect its host (Berger et al., 2005a), emphasizing the 
importance of the many innate defense mechanisms that patrol this integument. It is 
unclear if the adaptive immune system plays a vital role in protecting frogs from Bd 
(Berger et al., 1998a, Pessier et al., 1999, Berger et al., 2005b, Woodhams et al., 
2007a). Bd may impair the development of adaptive cell-mediated defenses because 
experimental exposure of frogs to heat-killed Bd zoospores failed to induce a 
subsequent protective immune response (Stice and Briggs, 2010). The presence of 
lymphocytes does not increase in infected frogs (Woodhams et al., 2007a). It has even 
been demonstrated that Bd can impair lymphocytes via apoptosis in vitro (Fites et al., 
2012) and may also impair a systemic immune response in vivo (Young et al., 2014). On 
the contrary, recent research does suggest that previously exposed frogs do acquire an 
immune response to Bd (McMahon et al., 2014), but only after several exposure and 
treatment regimens. Antimicrobial peptides (AMPs) have demonstrated the ability to 
 
 
17 
 
inhibit the growth of Bd in vitro (Conlon et al., 2013, Ramsey et al., 2010, Rollins-Smith 
et al., 2002c). However, even frog species susceptible to chytridiomycosis produce anti-
Bd AMPs (Rollins-Smith et al., 2002c, Woodhams et al., 2007b, Bosch and Rincón, 
2008, Parker et al., 2002, Conlon et al., 2007b),. 
Amphibians are one of the most endangered vertebrate groups (Stuart et al., 
2004), so developing mitigation strategies is critical. It is also unlikely that Bd will be 
eradicated from the environment, so mitigation strategies will rely on treatment or 
prophylactic methods directed at hosts. Although chytridiomycosis can currently be 
treated by the application of various anti-fungal drugs (Jones et al., 2012, Hadfield and 
Whitaker, 2005, Garner et al., 2009, Bowerman et al., 2010, Martel et al., 2011) or by 
heat therapy (Woodhams et al., 2003, Geiger et al., 2011, Chatfield and Richards-
Zawacki, 2011), these treatments aren’t always effective (Woodhams et al., 2012b) and 
would be difficult to apply in situ. Strategies that can protect vulnerable frogs may allow 
for populations to persist in their natural environment, and may improve understanding 
of how defenses like bacteria contribute to chytridiomycosis resistance and will guide 
future mitigation strategies. 
We tested if cutaneous bacteria are important in protecting wild marsupial frogs in 
a community decimated by Bd in Andean Peru (Catenazzi et al., 2011). Female 
marsupial frogs possess a dorsal brood pouch where fertilized eggs are stored until 
hatching. Then, depending on the species, either tadpoles are deposited into water, or 
embryos complete their development inside the pouch and emerge as froglets 
(Weinland 1854(del Pino and Escobar, 1981). Recently, cutaneous bacteria were 
identified from Ecuadorian marsupial frogs that have tadpoles (Bresciano et al., 2015). 
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The species of focus in our study, Gastrotheca nebulanastes and G. excubitor, develop 
directly from egg to froglet (Duellman and Maness, 1980). Prevalence of Bd infection 
was similar in these species in 2008 and 2009 (Catenazzi et al., 2011). 
 A previous study exposed both G. nebulanastes and G. excubitor to high 
numbers of zoospores in Bd susceptibility trials. The results indicated that G. 
nebulanastes is susceptible to chytridiomycosis (16.6% survival) while G. excubitor is 
resistant (100% survival) (Catenazzi, Vredenburg et al. unpublished) (Figure 1). To test 
if cutaneous bacteria contributed to the observed difference in susceptibility, bacteria 
were collected from individuals of both species. Isolates of these bacteria were then 
tested for their abilities to inhibit the growth of Bd in co-culture assays. Growth inhibition 
was quantified by measuring the change in the density of Bd colonies. The identities of 
the isolates were also determined via BLAST searches of the sequences of their 16S 
ribosomal RNA genes, and bacterial compositions were compared between the two host 
species, as well as with other frog species (Woodhams et al., 2015, Bresciano et al., 
2015). 
 
METHODS 
Study species and site 
Frogs were collected along the Paucartambo-Shintuya road in the eastern slopes 
of the Cordillera de Paucartambo, Cusco, Peru from June to August of 2012. 
Gastrotheca excubitor were collected in high elevation grasslands above 3,000 m and 
G. nebulanastes were collected in the montane scrub forests between 2,000 and 3,000 
m (Duellman et al., 2011). We captured juveniles and adults of both sexes. All frogs 
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were housed in individual plastic bags and taken to nearby Wayqecha Biological Station 
for bacterial and Bd sampling. 
 
Bacterial Sampling 
Samples of cutaneous bacteria were collected from 12 G. excubitor and 8 G. 
nebulanastes. Frogs were handled using sterile nitrile gloves and were rinsed twice with 
dechlorinated water to remove transient bacteria (Lauer et al. 2007). Frogs were then 
swabbed on their left, right, and ventral surfaces, hindlimbs, and interdigital membranes 
using a sterile cotton swab (Flechas et al. 2012). Each swab was streaked onto a Petri 
dish of nutritive agar and incubated at room temperature for up to two weeks. After this 
time Petri dishes were examined for bacterial growth and each bacterial morphotype 
(identified on the basis of color, form, elevation, and margin) was streaked onto a new 
plate with nutritive agar. This process was repeated until only similar morphotypes were 
consistently observed, at which time, a small portion of each isolate was collected onto a 
sterile cotton swab which was stored in a sterile vial. These were then transported to the 
laboratory for Bd growth inhibition assays, sequencing, and cryopreservation (nutritive 
broth with 30 % glycerol at – 80°C).  
 
Batrachochytrium dendrobatidis growth inhibition assays 
Each bacterial isolate was tested for its ability to inhibit the growth of Bd in a co-
culture assay (Harris et al. 2006) at Universidad de los Andes in Bogotá, Columbia. We 
isolated the Bd strain used in these assays from the mouthparts of a Hypsiboas gladiator 
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(Anura, Hylidae) tadpole captured along the Paucartambo-Shintuya road in June of 
2012. Bd was maintained in culture on TGh medium (10 g tryptone, 10 g agar, 4 g 
gelatin hydrolysate, 1 L distilled water) at 23˚C (Flechas et al. 2012). After maximum 
zoospore production was observed, Bd was harvested and combined in a sterile tube 
with 16 mL of sterile water. One mL of this zoospore rich solution was spread on to a 
Petri dish containing TGh medium and allowed to dry. An unknown isolate of bacteria 
from frog skin was streaked in a line across one side of the Petri dish, and as a negative 
control, Escherichia coli (strain DH5α), which does not inhibit the growth of Bd, was 
streaked across the other side of the Petri dish. Assays were set up in triplicate. Petri 
dishes were checked daily for contamination, and if a dish was contaminated it was 
removed and discarded. This was the reason for the removal of two replicates of one 
isolate and one replicate of another. Each Petri dish was grown at 23˚C for three days. 
On the third day each Petri dish was checked for Bd inhibition by the presence of a clear 
zone of inhibited Bd growth around the isolate. 
Analysis of inhibition assays 
The strength of a particular isolate’s ability to inhibit Bd was determined by 
quantifying the distance from the isolate to where 50% Bd growth occurred. Thus, 
isolates with stronger inhibitory abilities depressed Bd growth over longer distances. For 
one replicate it was unclear where 50% growth occurred; the sigmoidal shape of the 
graphed points surpassed this value twice (Figure 3). This was likely due to sparse and 
uneven Bd growth on the Petri dish; this replicate was removed from analysis.  
Bd growth was initially recorded by measuring the grey values of standardized 
photographs of the Petri dishes using ImageJ software (Abramoff et al., Flechas et al., 
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2012). Grey values (hereafter referred to as “growth”) are measurements of the intensity 
of light in a pixel of a black and white image. Growth was averaged among pixel wide 
columns across the area between the query bacterium and negative control, thereby 
quantifying growth over minute distance increments from the query. Distances between 
the query and the negative control varied slightly between Petri dishes, so they were 
expressed as percentages of the total length (i.e. relative distance) to facilitate 
comparative analysis. Growth was also expressed as percentage of the maximum 
growth recorded to control for any variation between Petri dishes. For each replicate, 
values were plotted on a graph using Microsoft Excel (Microsoft Corporation, Redmond, 
WA, USA). The distance at where 50% growth occurred was determined using the 
function of a line fit to the graphed values. We report average relative distance and 
standard error calculated across the three replicates of each isolate. 
Identification of bacteria 
Bacterial isolates were identified by sequencing the 16S ribosomal RNA (rRNA) 
gene. Swab samples of each isolate were stored frozen before processing. DNA was 
extracted from each swab using 80 µL Prepman Ultra Sample Preparation Reagent (Life 
Technologies Corporation, 2010). Tubes were then thoroughly vortexed, incubated at 
100°C for 10 min., cooled for 2 min., and then centrifuged at 1300 rpm for 3 min. 
Afterwards, 40 µL of the supernatant was removed and placed into a new sterile tube. 
This DNA-rich liquid was diluted with sterile water at a ratio of 1:100. A PCR reaction 
was performed using the diluted DNA as a template and the universal 16S bacterial 
primers 27F (5’-AGAGTTTGATCCTGGCTCAG-3’) and 1492R (5’-
GGTTACCTTGTTACGACTT-3’) (Lane, 1991). Each PCR reaction contained 1 µL of 
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each primer, 2 µL of the DNA template, 8.5 µL of sterile water, and 12.5 µL of GoTaq 
Green Master Mix (Promega Corporation, Madison, WI, USA). Thermocycling conditions 
were as follows: initial denaturation at 95°C for 2 min., 30 cycles at 95°C for 30 s, 60°C 
for 30 s, and 72°C for 90 s, and a final extension at 72°C for 10 min. Amplification was 
verified by electrophoresing 5 µL of the PCR sample on a 2% agarose gel. PCR 
products were cleaned using EXO-Sap It (Affymetrix, Inc, Santa Clara, CA, USA) and 
sent to MCLAB in San Francisco, California for sequencing.  
Sequences were annotated and assembled using GENIOUS software 
(Biomatters Limited, Auckland, New Zealand). All sequences were first checked for 
quality and only those with forward and reverse sequences consisting of at least 60% 
high quality base pairs were utilized. Assembled sequences were referenced to known 
microbial DNA sequences using the BLAST search of the NCBI database within 
GENEIOUS using the default parameters. Sequences were also cross referenced with 
the Greengenes database (http://greengenes.lbl.gov) using the default parameters to 
verify identities. Identities of nearest relatives were approximated to either the genus or 
species level (depending on the results of the BLAST searches) based upon the identity 
grades of the BLAST results.  
Sampling for Bd 
All individuals collected during the field sampling were swabbed for the presence 
of Bd. Sterile cotton swabs were streaked five times on each side of the animal, 
between its front and rear limbs, five times on the ventral “drink patch,” five times on the 
upper portion of each of the legs, and once on each interdigital membrane of the hind 
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feet (Hyatt et al., 2007). The swabs were immediately placed into individual sterilized 
vials and stored for processing.  
Swab samples were analyzed using real-time quantitative PCR (qPCR). DNA was 
extracted from swabs using PrepMan Ultra following the protocol outlined in Boyle et al. 
(2004) and Hyatt et al. (2007), except extracts were analyzed once instead of three 
times (Vredenburg et al., 2010). An Applied Biosystems Instrument 7300 PCR machine 
was used to quantify the amount of DNA in each sample. We calculated ZE, the 
genomic equivalent for Bd zoospores (henceforth “zoospores”) by comparing the qPCR 
results to a set of standards from live cultures. 
 
RESULTS 
Identification of bacteria via morphology and RNA sequencing 
A total of 24 bacterial morphotypes were isolated form the study species, 14 from 
G. excubitor and 10 from G. nebulanastes (Table 1). The nearest relatives for three of 
the anti-Bd strains (see below) isolated from G. excubitor were: Sphingobacterium 
faecium (99.7% identity grade), Janthinobacterium lividum (99.9% identity grade), and 
Rahnella aquatilis (99% identity grade) and were labeled as strains of these species. 
The other two isolates from G. excubitor were identified as members of the genus 
Pseudomonas, but because they lacked a clear nearest relative on the species level 
were designated with the labels Pseudomonas sp. 1 and Pseudomonas sp. 2. The 
nearest relatives for Pseudomonas sp. 1 are P. mandelii, P. poae, and P. trivialis (all 
99.4% identity grades). The nearest relatives for Pseudomonas sp. 2 are P. fluorescens, 
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P. poae, and P. trivialis (all 100% identity grades). These similar BLAST results indicate 
that these two isolates are probably closely related. However, they are morphologically 
distinct in culture.  
The single anti-Bd bacterium isolated from G. nebulanastes also belongs to the 
genus Pseudomonas. Due to ambiguity with identifying this isolate’s nearest relative on 
the species level, it was labeled Pseudomonas sp. 3. The two nearest relatives of 
Pseudomonas sp. 3 (100% identity grade) are also currently unidentified to the species 
level, but they are closely related to P. baetica and P. koreensis (99.9% identity grade).  
Among non-anti-Bd isolates (see below), one isolated from G. excubitor, had the 
same sequences of Pseudomonas sp. 2, suggesting variability in this isolate’s Bd 
inhibitory abilities. Six others from G. nebulanastes all had many nearest relatives within 
the genus Psuedomonas, including some that were shared with the Pseudomonas anti-
Bd isolates such as P. poae (99.9% identity grade), P. fluorescens (99.9% identity 
grade), and P. baetica (100%).  The nearest relatives for several non-anti-Bd isolates 
were identified to the species level, including Microbacterium oxydans (99.9 %) and 
Bacillus simplex (100% identity grade) from G. nebulanastes, and Aeromonas hydrophila 
(100%) and Acinetobacter radioresistens (99.9% identity grade) from G. excubitor.   
Batrachochytrium dendrobatidis growth inhibition assays 
From the inhibition assays, six out of the total 24 bacterial isolates tested 
produced zones of Bd inhibition. Of these, five came from G. excubitor and one from G. 
nebulanastes, so about a third of G. excubitor (five out of 14) isolates but a tenth of G. 
nebulanastes isolates (one out of 10) were labeled as anti-Bd (figure).  
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Analysis of the inhibition assays indicated that the bacterium labeled as 
Pseudomonas sp. 2, isolated from G. excubitor, had the strongest ability to inhibit the 
growth of Bd, with 50% Bd growth measured occurring at 66% of the total distance 
(Figure 4, Table 1). The J. lividum strain had the weakest inhibitory ability of all of the 
bacteria isolated from G. excubitor. For this isolate, 50% of Bd growth occurred at 40% 
of the total distance (Figure 4). The one isolate from G. nebulanastes that was inhibitory 
against Bd, Pseudomonas sp. 3, was the weakest of all the isolates from both species. 
For this isolate, 50% of Bd growth occurred at 38% of the total distance (Figure 4). 
Prevalence and infection load for Bd 
Only four G. nebulanastes (prevalence= 25%, CI=7.6%-46.8%) but 13 G. 
excubitor (prevalence= 46.4%, CI=28.9%-64.3%) tested positive for Bd. All Bd positive 
frogs had low infection loads (< 350 zoospore), except for one G. excubitor, with 
26,208.8 zoospore.   
 
DISCUSSION  
The frog species resistant to chytridiomycosis, G. excubitor, harbors more 
cultivable anti-Bd skin bacteria than a susceptible congeneric, G. nebulanastes. 
Gastrotheca excubitor also has proportionally more cultivable bacteria that inhibit the 
growth of Bd than G. nebulanastes (36% versus 10%, respectively). These results 
suggest that chytridiomycosis resistance may be correlated with the number and 
proportion of a frog species’ anti-Bd skin bacteria. This relationship has also been 
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suggested by other studies that found similar results (Park et al., 2014, Woodhams et 
al., 2007b, Lam et al., 2010, Lam et al., 2008, Flechas et al., 2012). 
All of the six anti-Bd bacterial morphotypes had relatively similar strengths of 
inhibition with distances to 50% Bd growth ranging from 38%-66% of the total distance 
(Figure 4). The isolate with the strongest ability to inhibit Bd belongs to the genus 
Pseudomonas (Figure 4). Two other isolates were identified as members of this genus, 
the fourth strongest and the weakest (Figure 4, Table 1). Pseudomonas bacteria are 
common inhabitants of frog skin and are frequently characterized by having strong anti-
Bd properties (Flechas et al., 2012, Walke et al., 2011, Brucker et al., 2008, Lam et al., 
2010). The nearest relatives of two isolates, S. faecium and J. lividum, are known for 
their anti-Bd abilities; for example S. faecium has been isolated from Alytes obstetricans 
in Switzerland, a toad species whose susceptibly to Bd varies by population (Tobler and 
Schmidt, 2010).  
The presence of J. lividum on the skin of G. excubitor is of particular interest. 
Anti-Bd strains of this bacterium have been isolated from multiple species of amphibians 
from Europe and the United States (Woodhams et al., 2015). This bacterium has also 
been applied successfully as a probiotic in laboratory experiments (Harris et al., 2009b, 
Harris et al., 2009a) and in one emergency application to a declining population of Rana 
muscosa in the wild (Vredenburg et al., 2011), although the latter experiment did not 
have a control group. Despite J. lividum being well-known for the strong anti-Bd 
properties of its metabolites violacein and indole-3-carboxaldehyde (Brucker et al., 
2008), the closely related strain that we isolated was ranked as the second weakest out 
of six isolates (Figure 4). Our strain also lacks the distinctive purple coloration 
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characteristic of J. lividum in culture, attributed to the production of violacein. It is 
possible that our strain does not produce violacein but still produces indole-3-
carboxaldehyde, making it less able to inhibit Bd than other J. lividum strains.   
Although not previously known for its ability to inhibit the growth of Bd, we found 
that Rahnella aquatilis, isolated from G. excubitor, was a relatively strong inhibitor of Bd 
(Figure 4). This bacterium has been documented as an antifungal symbiont of the 
Chinese beetle Dendroroctonus valens (Winder et al., 2010). The two isolates from G. 
excubitor in the genus Pseudomonas were both closely related to Pseudomonas poae 
(99.4% identity grade for Pseudomonas sp. 1 and 100% identity grade Pseudomonas 
sp. 2), documented as an antifungal symbiont of the sugar beet (Müller et al., 2013). 
Although both the isolates Pseudomonas sp. 1 and Pseudomonas sp. 2 had similar 16S 
rRNA sequences, their morphologies were distinct and they differed in their abilities to 
inhibit Bd (with 50% Bd growth occurring at 43.33% and 65.94% of the total distances, 
respectively). We found that a non-anti-Bd isolate was also identified as Pseudomonas 
sp. 2 because of their identical 16S rRNA sequences. Additionally, several non-anti-Bd 
Pseudomonas isolates shared similar nearest relative BLAST results to these anti-Bd 
Pseudomonas strains. These findings suggest that functional variance can occur 
between closely related, or even same-species, strains.  
The one anti-Bd strain from G. nebulanastes, labeled as Pseudomonas sp. 3, 
shares a 100% identity grade with a bacterium isolated from peat moss in the United 
Kingdom (Hill et al., 2014) and another, capable of producing aromatic compounds, 
isolated from soil underneath logs in the Netherlands (Bandounas et al., 2011). The 
latter is closely related to another bacterium with documented antifungal properties; it is 
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pathogenic to the mushroom Agaricus bisporus (Godfrey et al., 2001). Although labeled 
as anti-Bd on the basis of its inhibition zone in one replicate, the removal of the second 
replicate (see methods) brings into question the integrity of its inhibitory abilities. 
Therefore, we label Pseudomonas sp. 3 as potentially anti-Bd and suggest further 
testing to verify its anti-Bd ability. 
None of the bacteria identified were shared between the two Gastrotheca 
species. These frogs differ in the niches that they inhabit, with G. excubitor dwelling 
under rocks and among bunchgrasses on the ground of grasslands and G. nebulanastes 
in the bushes and trees of the scrub forest. Our findings suggests that the environment 
might be an important source of inoculation for skin bacteria. We also found that only J. 
lividum and Aeromonas hydrophila, isolated from G. excubitor, were shared with the 
Ecuadorian congeneric G. riobambae sampled by Bresciano et al. (2015). Interestingly, 
this study considered A. hydrophila as anti-Bd, and we did not. However, unlike our 
study, Bresciano et al. (2015) did not conduct growth inhibition assays to validate the 
classification of their bacteria. This difference, along with our varying results for 
Pseudomonas sp. 2, exemplifies the importance of considering the variance in the 
antimicrobial abilities of closely related strains. 
The results of our study support the notion that cutaneous bacteria may be 
important in providing frogs with protection against Bd (Conlon et al., 2007b). Previously, 
it had been suggested that frogs fail to develop an adaptive immune response (Stice 
and Briggs, 2010) and that proliferation of lymphocytic cells is hindered by Bd (Fites et 
al., 2012). In addition, the expression of AMPs does not consistently correlate with 
resistance to Bd (Rollins-Smith et al., 2002c, Woodhams et al., 2007b, Bosch and 
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Rincón, 2008, Parker et al., 2002, Conlon et al., 2007b), and the reduction of these 
defenses has not been demonstrated to increase susceptibility (Woodhams et al., 
2012a) as does the reduction of anti-Bd skin bacteria (Becker and Harris, 2010). A 
concurrent study conducted by our group found that natural mixtures of AMPs collected 
from G. excubitor and G. nebulanastes did not differ in their abilities to inhibit the growth 
of Bd in vitro, emphasizing the role of the anti-Bd bacteria found here in protecting G. 
excubitor. 
The use of anti-Bd bacteria in bioaugmentation therapy is promising, but the strict 
requirements of potential probiotics (Bletz et al., 2013) will require wide scale sampling 
of cutaneous microbes from many frog species. Here we have discovered at least four 
novel anti-Bd strains that will contribute to the library of these potential candidates. We 
did not, however, find any anti-Bd isolates shared between the Gastrotheca species, 
which suggests that similarities in cutaneous bacterial compositions cannot be assumed 
between congeneric species. Bletz et al. (2013) recommends as probiotic a bacterium 
that naturally occurs on the susceptible frog. In our study, the only candidate for 
bioaugmentation therapy for G. nebulanastes is Pseudomonas sp. 3, whose anti-Bd 
capabilities are questionable. If its inhibitory abilities are eventually verified, however, 
this bacterium should be considered as a candidate for bioaugmentation therapy with G. 
nebulanastes. Since the females of this species keep eggs in their dorsal brood pouch 
until the hatching of froglets (Duellman et al., 2011), vertical transmission of cutaneous 
bacteria between a mother and offspring is likely. Therefore, a probiotic applied to a 
portion of wild females of this species may proliferate throughout generations. 
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CONCLUSIONS: 
The process towards developing an effective mitigation strategy for 
chytridiomycosis is an iterative approach that continues to unveil the complexity of the 
host-pathogen system. It is likely that bacteria may provide an answer and the results of 
our research are encouraging. The intricate ecology of the frog mucosome must first be 
untangled to know for certain. Outside the scope of the frog’s immune system, inter- and 
intraspecific interactions, environmental factors, and anthropogenic forces likely play 
major roles in the patterns of either post-Bd population declines or persistence. Despite 
this daunting complexity, however, each discovery is a step forward towards 
understanding the host-pathogen relationship and brings hope for saving an imperiled 
animal group.   
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Table 1: Species of cultured bacteria isolated from Gastrotheca excubitor and G. 
nebulanastes 
______________________________________________________________________ 
Bacterial Species                            G. exc.     G. neb.     Anti-Bd      Rank of anti-Bd 
Actinobacteria 
Actinomycetales: Microbacteriaceae 
Microbacterium oxydans   -  + No            
Microbacterium sp.                      +  - No 
Bacteroidetes 
Flavobacteriales: Flavobacteriaceae 
Chryseobacterium sp.                 +  - No                            
Sphingobacteriales: Sphingobacteriaceae 
Sphingobacterium faecium       +  - Yes  3  
Firmicutes      
Bacillales: Bacillaceae 
Bacillus simplex                 -  + No 
Bacillus sp.                          -  + No 
Bacillales: Paenibacillaceae 
Paenibacillus sp.    -  + No 
Proteobacteria 
Aeromonadales: Aeromonadaceae 
Aeromonas hydrohphila   +  - No                       
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Table [1]: Continued 
 
Bacterial Species                            G. exc.     G. neb.     Anti-Bd      Rank of anti-Bd 
Burkholderiales: Oxalobacteraceae 
Janthinobacterium lividum   +  - Yes  5 
Enterobacteriales: Enterobacteriaceae 
Rahnella aquatilis    +  - Yes  2 
Serratia sp.                           +  - No 
Pseuodomonadales: Moraxellaceae 
Acinetobacter radioresistens    +  - No   
Pseudomonadales: Pseudomonadaceae 
Pseudomonas sp. 1                +      - Yes  4 
Pseudomonas sp. 2                    +            - Yes  1  
Pseudomonas sp. 3                     -                   + Yes  6 
Pseudomonas sp. 4                                  -  + No                           
Pseudomonas sp. 5                    -  + No 
Pseudomonas sp. 6    -                   + No 
Pseudomonas sp. 7                              -                    + No 
Pseudomonas sp. 8                                 -  + No 
Sphingomonadales: Sphingomonadaceae 
Sphingomonas sp.    +  - No 
______________________________________________________________________ 
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Figure 1: Kaplan-Meier Survival Curves for G. nebulanastes (top) and G. excubitor 
(bottom). The infected group is represented in black and the control group in red. 
Infected and control G. excubitor did not differ in survivorship. 
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Figure 2: Examples of bacterial isolates exhibiting clear zones of Bd inhibition and 
therefore designated as anti-Bd. 
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Figure 3: The growth inhibition curve for a replicate of the Pseudomonas sp 3 isolate. 
Because the line of this graph passes through 50% growth (0.32% total Bd growth 
based on the equation of the line) twice, it was excluded from further analysis.  
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Figure 4: Mean distances (with standard errors) to 50% growth for each isolate. 
Sphingobacterium faecium and Pseudomonas sp. 3 do not have standard error bars 
because they each had only 1 replicate. 
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CHAPTER 3 
SUSCEPTIBILITY TO CHYTRIDIOMYCOSIS DOES NOT CORRELATE WITH 
ANTIMICROBIAL ABILITIES OF CUTANEOUS PEPTIDES IN TWO SPECIES OF 
MARSUPIAL FROGS 
INTRODUCTION 
Antimicrobial peptides (AMPs) are an important component of the innate immune 
system for many organisms including both vertebrates and invertebrates. AMPs are 
functionally diverse but all share the ability to form an amphipathic shape characterized 
by distinct hydrophobic and cationic amino acid groups. This structure allows AMPs to 
efficiently target cellular membranes and induce lysis (Amiche et al., 1999, Conlon et al., 
2004b, Pasupuleti et al., 2012). An AMP’s positive charge facilitates binding to bacterial 
or fungal outer membranes which are composed of many negatively charged 
phospholipids (Nicolas and Mor, 1995, Zasloff, 2002). Because of its hydrophobicity, an 
AMP can also penetrate its target’s cellular membrane, creating fatal pores (Yang et al., 
2000). It is suggested that cellular death is induced by depolarization of the membrane 
(Westerhoff et al., 1989), reorganization of the lipid bilayer (Matsuzaki, 1999), or by the 
peptide entering the cell and disrupting enzymatic activity (Kragol et al., 2001). 
Evolutionarily, AMPs are an ancient defense mechanism and are therefore 
probably important for basal vertebrates like amphibians. Invasion of pathogens through 
porous skin is problematic for these animals, emphasizing the efficiency of cutaneous 
defenses like AMPs. It is suggested that AMPs may even assist with the delivery of 
neuroactive peptides in toxic amphibians by disrupting the cellular membranes of their 
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predators (König et al., 2015, Conlon, 2011). Because they can be proficient killers, 
especially in anurans, amphibian AMPs have been tested for biomedical applications, 
demonstrating activity against Chlamydia trachomatis (Bergaoui et al., 2013), human 
immunodeficiency virus (VanCompernolle et al., 2005), and tumor cells (Mechkarska et 
al., 2014). 
In frogs, activation of the sympathetic nervous system stimulates cutaneous 
granular glands to release AMPs which are combined with a mucous to coat the skin 
(Bovbjerg, 1963, Mills and Prum, 1984, Rollins-Smith et al., 2005). Since they are 
present on the skin, AMPs could play a role in protecting frogs from cutaneous 
pathogens like the fungus Batrachochytrium dendrobatidis (Bd) (Longcore et al., 1999). 
This pathogen has caused numerous frog population collapses in many parts of the 
world (Berger et al., 1998a, Daszak and Berger, 1999, Skerratt et al., 2007, Fisher et al., 
2009). Bd infects frogs via motile zoospores that encyst on their skin (Berger et al., 
2005a, Kilpatrick et al., 2010) and can cause the fatal disease chytridiomycosis (Berger 
et al., 2005b).  
Natural peptide mixtures collected from frogs have successfully demonstrated the 
ability to inhibit the growth of Bd in laboratory assays (Rollins-Smith et al., 2002c, 
Conlon et al., 2013, Woodhams et al., 2010a, Ramsey et al., 2010). The collection of 
peptides is typically induced by injecting the frog with norepinephrine to stimulate its 
sympathetic nervous system (Rollins-Smith et al., 2002c, Nutkins and Williams, 1989). 
Bd growth inhibition is then assayed using different dilutions of natural peptide mixtures 
to establish a minimum inhibitory concentration (MIC) where growth of a known number 
of zoospores is completely inhibited (Woodhams et al., 2006b, Rollins-Smith et al., 
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2006). MIC values can be used to compare the relative effectiveness of AMPs among 
individuals or species.  
Here, we analyze peptide samples from two marsupial frogs, Gastrotheca 
excubitor and G. nebulanastes. Whole peptide mixtures collected from these frogs were 
tested for their abilities to inhibit the growth of Bd in vitro and the peptide profile of each 
sample was generated by mass spectrometry. The results contribute to understanding 
the role that AMPs play in protecting frogs from chytridiomycosis because G. excubitor is 
resistant and G. nebulanastes is susceptible (Catenazzi, Vredenburg et al. unpublished). 
These species live in the Andes Mountains of south eastern Peru, where surveys 
indicate that anuran species diversity was reduced by approximately 36% following the 
arrival of Bd at the turn of the millennium (Catenazzi et al., 2011).  
 
METHODS 
Study species 
Marsupial frogs (family Hemiphractidae) occur from Central America to southern 
South America. These frogs are unique in that the females possess a dorsal brood 
pouch where eggs develop until hatching as either a tadpole or a froglet (direct-
developing) depending on the species (Weinland 1854, del Pino and Escobar, 1981). 
Both G. nebulanastes and G. excubitor are medium-sized, direct-developing frogs 
endemic to the Andean region of southeastern Peru. These two species are 
morphologically similar and were thought to be the same species until 2011 (Duellman et 
al., 2011). The susceptible G. nebulanastes inhabits montane scrub and cloud forests 
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from 2,000-3,300 m. They are primarily found on shrubs and the rocks of cliffs caused 
by landslides or along roads (Duellman et al., 2011). The resistant G. excubitor is 
marginally sympatric to G. nebulanastes but lives above 3,100 m on vegetation in high-
Andean grasslands.  
Study site 
Field work was conducted in the Kosñipata Valley of southeastern Peru. Surveys 
indicated that the number of frog species present in the montane area (1200 – 3800 m) 
has declined by approximately 36% from 1999 to 2008 and 2009, and is significantly 
correlated with prevalence of Bd along the elevational gradient (Catenazzi et al., 2011). 
Both G. nebulanastes and G. excubitor can be found near the Wayqecha Biological 
Station (WBS) located at 2900 m on the mountainside of the valley. This research 
station is just outside of Manu National Park in the region of Cusco. Its property 
encompasses cloud forests, montane scrub forests, and grasslands from 2200 m to 
3700 m. The Paucartambo-Shintuya Road runs through these ecosystems and provides 
easy access. 
Collection of frogs 
Visual encounter surveys performed from May to July of 2014 recovered 36 G. 
nebulanastes and 47 G. excubitor in the area surrounding WBS. Gastrotheca 
nebulanastes were collected by walking along the Paucartambo-Shintuya Road at night, 
where males were found calling from rocks and vegetation and juveniles were foraging. 
No females were encountered during the sampling period. Previously recorded calls 
were played to maximize the chance of locating calling males. Gastrotheca excubitor 
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were collected during the day by searching under rocks, in bunchgrasses, and in moss 
in the high-elevation grasslands they inhabit. Males, females and juveniles of this 
species were all commonly encountered and therefore all were included in the sampling.  
Frogs were collected by inverting a plastic bag over the collector’s hand, reducing 
any risk of contamination from the collector’s skin (Robertson et al., 2013, Woodhams et 
al., 2006a). A small piece of nearby vegetation, collected in the same manner, was 
placed in each bag to provide moisture for the frog. Following a survey, all collected 
frogs were brought back to WBS, stored in their individual bags in a cool location away 
from direct sunlight, and sampled for peptides within 24 hours. Afterwards they were 
released in the area at which they were found.  
Sampling for Antimicrobial Peptides 
Peptide secretion was stimulated by the injection of norepinephrine into each 
frog’s dorsal lymph sack (Rollins-Smith et al., 2002c, Nutkins and Williams, 1989). 
Norepinephrine injection provides a more standardized peptide collection technique 
alternative to transdermal electrical stimulation, which requires calibration between 
species and is thought to be more harmful (Tyler et al., 1992, Woodhams et al., 2006a).  
Specifically, 0.1 ml of injection solution prepared as described below (Holden et al., 
2015) was administered per gram of frog body weight (Table 2). To obtain this 
concentration in the field, pre-weighed quantities (0.675 mg) of norepinephrine were 
combined with 5 ml of amphibian phosphate buffered saline (APBS, Table 2) and mixed 
by vortex to produce a 40 nmol solution. This solution was then passed through a 0.22 
m filter to sterilize it before use. A fresh batch of injection solution was made before 
each AMP sampling.  
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Prior to injection, the frog’s entire body was first rinsed for five seconds with 
deionized water to remove any transient contaminants and dirt from its skin. The frog 
was then placed into a sterile Whirl- Pak® bag (Nasco, Fort Atkinson, WI, USA) and 
weighed to determine the volume of injection solution to administer. The frog was 
manipulated to the top of the bag (without making contact with it) and the norepinephrine 
solution was injected through the bag and into the frog’s dorsal lymph sack using a 1 mL 
syringe with a new, sterile 5/8 inch 25 gauge needle for each frog. Immediately after 
administering the injection solution, 25 ml of HPLC grade water was added to the bag as 
a medium for peptide collection. The frog remained in the bag for 15 min, enough time to 
allow the maximum amount of skin secretions to collect in the water before the peptides 
may begin to degrade (Rollins-Smith et al., 2002c). 
After 15 min, the frog was removed from the bag and 1 ml of 50% HCl (Table 2) 
was added to the sample (Woodhams et al., 2006b) to inactivate any endogenous 
peptidases that may be present (Resnick et al., 1991, Steinborner et al., 1997). The 
samples were partially purified by passing them through Sep Pak cartridges (Waters 
Corporation, Milford, MA, USA) (Goraya et al., 1998) that had previously been activated 
by passing 10 mL of ethanol and then 10 mL of Buffer A (Table 2).  Using a 60 mL 
syringe, the entire volume of the collection water and skin secretions was collected from 
the bag, pushed through a single Sep Pak cartridge at a rate of two drops per second 
and collected in a waste container (Louise Rollins-Smith, pers. comm.). The cartridges 
were then placed back in the Whirl-Pak® storage bags and kept with 2 mL of Buffer A to 
stay moist until processing. Meanwhile, the frog was swabbed for Bd (see below), 
measured for snout to vent length, and sexed.  
 
 
43 
 
Elution of peptides from skin secretion samples  
After collection, the skin secretion samples were transported to Vanderbilt 
University and peptides were eluted from the Sep Pak cartridges by Laura Reinert in the 
Rollins-Smith lab. Elution was achieved by passing the samples through a vacuum pump 
set to 3 rpms. First, 10 mL of Buffer A were passed through the cartridges and into a 
waste container to remove any unwanted material that may have been lodged in the 
filter. Then, each cartridge was flushed with 11 mL of Buffer B, containing acetonitrile 
which liberated the bound peptides. The resulting solution was collected in sterile, 
individual 50 mL conical tubes. One mL from each sample was removed and placed into 
a mini Eppendorf tube and stored at -80˚ C for peptide quantification (see below). The 
remaining 10 mL of each sample was vacuum-centrifuged to dryness. The lyophilized 
peptides were then re-suspended in HPLC water, each at a concentration of 1 mg/mL 
(based on the quantity recovered per sample as determined by microBCA protein 
assays, see description below) for composition analysis (Louise Rollins-Smith, pers. 
comm.). 
Quantifying peptides in skin secretion samples 
Peptide concentrations per each sample were quantified using a Pierce 
microBCA protein assay kit (Thermo Scientific, Rockford, Illinois). The assay tests 1:10 
dilutions and non-diluted skin secretion samples against standards (200, 40, 20, 10, 5, 
2.5, 1, and 0.5 µg/mL). The manufacturer’s protocol was followed, except the peptide 
bradykinin (RPPGFSPFR) was used to determine the standards (Rollins-Smith et al., 
2002c, Smith et al., 1985). Solutions were plated on a 96-well plate with the standards 
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and blanks (Buffer B only) as negative controls, all in triplicate to increase the accuracy 
of comparisons (Louise Rollins-Smith, pers. comm.). Next, the plate was incubated at 
37˚C for two hours then cooled to room temperature for 10 minutes. The absorbance of 
each well was analyzed using an absorbance microplate reader at 570 nm. The results 
for each sample were compared with the standards to determine a peptide quantity per 
sample. One juvenile G. excubitor sample was removed from analysis because it 
contained no peptides.   
Bd growth inhibition assays 
Whole peptide mixtures were tested in vitro by dilution assays for their ability to 
inhibit the growth of Bd zoospores (JEL 197, J. E. Longcore, University of Maine). Only 
individual samples with enough peptide mixtures after resuspension (at least 600 µL at 1 
mg/mL) to complete an assay were tested for growth inhibition (n= 9 for G. excubitor and 
8 for G. nebulanastes). Bd was maintained at 19˚C in flasks with 1% tryptone broth 
containing penicillin and streptomycin to inhibit bacterial growth. Only zoospores were 
used because they are the infectious propagules of Bd (Rollins-Smith et al., 2002a). 
Zoospore harvesting was initiated by first scraping the sides of flasks (containing at least 
one week of growth, indicated by the presence of flakes of mature thalli) with a sterile 
inoculation loop to remove any zoospores that were against the sides. Two mL of 
solution was then removed from these flasks, flooded onto agar plates (tryptone, agar, 
glucose), and dried under a laminar flow hood. These plates were then incubated at 19-
20˚C until swarms of active zoospores were visible, typically three to seven days. 
Zoospores were harvested by flushing plates with tryptone broth and then passing the 
liquid through a 20 µm filter in a Buckner Funnel attached to a vacuum flask. This filter 
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size traps the mature thalli but allow zoospores to pass. The resulting zoospore-rich 
broth was then transferred from the vacuum flask to a sterile 50-ml conical tube. A 
sample of this solution, diluted in broth (1:10), was removed and placed onto a 
hemocytometer to count zoospores. This value was used to dilute the original zoospore 
rich solution to a concentration of 1x106 zoospores/ml.  
The peptide-Bd inhibition assays were conducted on 96-well microtiter flat-bottom 
plates, one plate per an individual frog’s peptide sample. Each well contained a total of 
100 µL; the assay consisted of five replicates each of: positive controls for Bd growth 
(50 µL zoospore solution and 50 µL HPLC water), negative controls for Bd growth (50 
µL zoospore solution, placed in a 60 ˚C water bath for 10 min to heat kill zoospores, and 
50 µL HPLC water), and peptide dilutions at 500, 250, 100, 50, 25, 12.5, 6.25, and 3.125 
µg/mL of whole peptide mixtures (50 µL peptide solution and 50 µL zoospore solution). 
Because plating of the assay resulted in diluting the zoospore solution 1:2, the final 
concentration tested for growth inhibition was 5x105 zoospores/ml. The absorbance (A) 
at 490 nm (A490) (Rollins-Smith et al., 2002c) was immediately recorded of each well 
using a Fisher Scientific  accuSkan GO UV/VIS microplate spectrophotometer (Fisher 
Scientific, Hampton, NH, USA). Plates were then covered by a lid, sealed with Parafilm 
(Bemis NA, Neenah, WA, USA), and incubated at 19-20˚C for seven days. On the 
seventh day, the A490 was recorded again. Plates were regularly checked for 
contamination by visual inspection, and any plates or wells that were contaminated were 
excluded from analysis. Any assays with more than three excluded wells within a 
treatment were removed from analysis.  
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Peptide Composition analysis via MALDI TOF mass spectrometry 
Peptide composition profiles were obtained for each individual frog sample (n= 36 
for G. nebulanastes and 47 for G. excubitor) via matrix-assisted laser desorption 
ionization (MALDI) time-of-flight (TOF) mass spectrometry (Woodhams et al., 2006b, 
Rollins-Smith et al., 2006). Mass spectrometry was performed at SIUC on a Thermo 
Scientific TraceGC PolarisQ Mass Spectrometer (Thermo Fisher Scientific, Waltham, 
MA, USA) in linear mode. The instrument was calibrated using the following standards 
(Sigma Aldrich, St. Louis, Missouri USA): bradykinin (m/z 904.468), angiotensin I (m/z 
1296.685), Glu-Fibrinopeptide B (m/z 1570.677), ACTH 1-17 (m/z 2093.085), ACTH 16-
39 (m/z 2465.199), and insulin oxidized B chain (m/z 3494.6513). Combined standards 
were mixed with matrix (10mg/mL α-cyano-4-hydroxycinnamic acid, 50% acetonitrile, 
49.9% MilliQ water, 0.1% trifluoroacetic acid) at a ratio of 1:25 and peptide samples 
were mixed with matrix at a ratio of 1:1. Both were spotted onto a MALDI plate, 
alternating rows between samples and standards so that every sample spot was 
adjacent to a standard spot.  
Sampling for Bd 
All individuals collected during the cutaneous peptide sampling were sampled for 
the presence and quantification of Bd infection. For each frog, a sterile cotton swab was 
streaked five times each on the side, between the front and rear limbs, the ventral pelvic 
patch, the upper portion of each of the legs, and once on each interdigital membrane of 
the hind feet (Hyatt et al., 2007). The swabs were immediately placed into individual 
sterilized vials until processing by real time PCR. PrepMan Ultra was used to extract 
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DNA from the swabs using the protocol outlined in Boyle et al. (2004) and Hyatt et al. 
(2007), except extracts were analyzed once (Vredenburg et al., 2010). Real time PCR 
was carried out on an Applied Biosystems StepOnePlus PCR machine to calculate the 
genomic equivalent, ZE for Bd zoospores (henceforth “zoospores”). This method 
quantifies these genomic equivalents by comparing each sample to a set of diluted 
standards from 100 to 0.1 genomic equivalents of zoospores.  
Statistical Analysis 
All statistical analyses were completed using R version 3.0.3 (R Foundation). 
Peptide amounts recovered were log transformed to meet the requirements of normality. 
These values were then compared between species and sex and life stage (includes 
males, females, and juveniles) using a two-way analysis of variance (ANOVA) with 
Tukey’s post hoc test (n=3 for G. nebulanastes juveniles, 33 for G. nebulanastes males, 
22 for G. excubitor juveniles, 12 for G. excubitor males, and 12 for G. excubitor 
females). Additionally, the amounts of peptides were compared between sex and life 
stage within G. excubitor (to look for differences among groups within a single species) 
using a one way ANOVA with Tukey’s post hoc tests. This analysis was not done for G. 
nebulanastes because, besides three juveniles, only males were sampled. 
 Data from inhibition assays were normally distributed (indicated by plotting 
quantiles), thus outliers were removed from analysis after using Dixon’s Q test (Holden 
et al., 2015). Positive control wells with no Bd growth and negative control wells with Bd 
growth were also excluded from analysis. For each well, the A490 from the first day was 
subtracted from that of the seventh day to determine A490. Mean A490 for the five 
negative control wells was then subtracted from every well to account for any change in 
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A490 not attributed to Bd growth. These resulting values were then taken as a 
percentage of mean A490 for the positive control wells to standardize measurements 
across assays for statistical comparisons. The resulting percentages (pA490) 
represented Bd growth in each experimental well after the seven day period. pA490 < 1 
represented Bd growth inhibition, while pA490 > 1 represented enhanced Bd growth. 
The abilities for individual peptide mixtures to inhibit the growth of Bd were visualized 
graphically by plotting the average percent of Bd growth for the different peptide 
concentrations and the controls (Figures 6-7). For a peptide mixture to be considered 
inhibitory it had to both significantly inhibit Bd growth at high concentrations and also 
exhibit an overall negative correlation with Bd growth as concentration decreased.  
Due to the design of the experiment, the amount of Bd growth among peptide 
dilutions and between species was compared by a split plot ANOVA design (Figure 10). 
The design treated individual frogs as a random effect nested within species and used 
the average amount of growth (the average of the five replicates) for each concentration 
within an individual. This design facilitated the statistical comparison of both frog species 
and dilution as factors in a single analysis. The model was adjusted with a Kenward-
Roger Degrees of Freedom Approximation and paired with a Tukey’s post hoc test. 
Peptide profiles generated by MALDI TOF mass spectrometry were analyzed 
using the software Flex Analysis (Bruker, Billerica, MA, USA) to mark the masses in 
Daltons (m/z) and intensities (counts per second) of peptide signals. The occurrence of 
peptide signals were then compared among individuals between species and life 
stage/sex, among individuals used for growth inhibition assays, and between individuals 
that tested positive and negative for Bd. Only signals with strong intensities (>10% of the 
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total intensity measured) and mass to charge ratios within the range of the standards 
were included in the analysis. Signals within 2 Daltons were considered to be the same 
peptide, and those that were 22 (+/- 2) Daltons greater were considered to be the 
sodium adducts of the same peptide. Correlations between Bd inhibitory or enhancing 
assayed samples and the presence of common peptide signals (shared by two or more 
assayed samples) were determined using a one way ANOVA.  
 
RESULTS 
Amounts of peptides in skin secretion samples 
Peptide amounts did not vary between G. nebulanastes and G. excubitor (Figure 
2; df= 1, 77; p= 0.363), but amounts varied among life stages/sex (df=2,77 p<0.001) and 
due to an interactive effect between species and life stage/sex (df=1,77 p=0.013). 
Tukey’s post hoc test indicated that the amounts of peptides recovered were lower in G. 
nebulanastes juveniles than in G. excubitor juveniles (df= 1,77 p= 0.011), G. excubitor 
females (df=1,77 p< 0.001), G. excubitor males (df= 1,77 p< 0.001), and G. 
nebulanastes males (df=1,77 p<0.001) (Figure 5).   Within G. excubitor smaller peptide 
amounts were recovered from juveniles than from males (df= 2,43 p=0.012) or females 
(df=2,43 p=0.009).  
Bd growth inhibition assays 
Four out of the eight (50%) peptide samples from G. nebulanastes and five out of 
the nine (56%) samples from G. excubitor inhibited Bd (Figures 6-9). Gastrotheca 
species did not differ in their abilities to inhibit the growth of Bd (Figure 11, split-plot 
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ANOVA, df=1,15 p=0.96), but there was a difference in concentration (df=7,105 
p=0.046). There was no interaction between species and peptide concentration 
(df=7,105 p=0.86). Inhibition was higher at 500 µg/mL than at 6.25 µg/mL (Tukey’s post 
hoc test, df= 7,105 p=0.016).  
Analysis via MALDI TOF mass spectrometry 
The most common peptide signal shared between the two Gastrotheca species 
had a mass to charge ratio of 1430 +/- 2 Daltons; also present was its sodium adduct at 
1452 +/- 2 Daltons. This signal occurred in 59% (27 of the 46) of the G. excubitor 
sampled, and in only one G. nebulanastes. Another frequent signal occurred at 1128 +/- 
2 Daltons (Table 3). Interestingly, only G. excubitor expressed the peptide in this form 
(n=6), but both species expressed the sodium adduct at 1150 +/- 2 Daltons (four G. 
excubitor and nine G. nebulanastes). The frog species differed in the expression of 
several peptides. Most notably only G. nebulanastes, but 53% of sampled individuals, 
had a signal at 1688 +/- 2 Daltons. There was no correlation between peptide type and 
Bd growth inhibition or enhancement, except for a peptide at 1298 +/- 2 Daltons found in 
assayed G. excubitor samples. This peptide was correlated with Bd growth 
enhancement (ANOVA, df=1,7 p=0.011). 
Prevalence and intensity of Bd infection 
Five out of 36 G. nebulanastes (14%, CI=5%-26%) and eight out of 46 G. 
excubitor (17%, CI=8%-29%) tested positive for Bd. Infection levels varied from 0.14-
125.66 zoospores in G. nebulanastes and from 0.04-1223.23 zoospores in G. excubitor. 
Of the assayed peptide samples, one came from an infected G. nebulanastes and one 
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came from an infected G. excubitor. This G. nebulanastes had a low infection level 
(ZE=0.69 zoospores) and its peptides exhibited Bd growth enhancement. The G. 
excubitor was the most infected individual (ZE=1223.23 zoospores) and its peptides 
were relatively strong Bd growth inhibitors (70% maximum Bd growth at 500 µg/mL) 
(Figure 8). There were no correlations between Bd infection and presence of peptide 
signals.  
 
DISCUSSION: 
The peptides we analyzed, from the Bd-susceptible Gastrotheca nebulanastes 
and the Bd-resistant G. excubitor, did not differ between species in quantity (Figure 5) or 
in their abilities to inhibit the growth of Bd (Figure 11). However, there was considerable 
variation among individuals, and some peptide samples exhibited patterns of growth 
inhibition while some exhibited growth enhancement (Figures 6-9).  
Peptide profiles failed to completely explain variation among individuals because 
most peptide signals occurred in both inhibitory and enhancing peptide samples. Only 
the peptide at 1298 +/- 2 Daltons showed correlation with Bd growth enhancement in 
assayed G. excubitor samples. It is very likely that this peptide cannot inhibit Bd growth; 
and perhaps it is responsible for enhancing it by providing nourishment for zoospores. 
Although there were some shared peptide signals, overall each species produced 
unique peptide profiles suggesting interspecific variation that is consistent with previous 
research (Woodhams et al., 2007a, Rollins-Smith et al., 2006).  
None of the assayed samples were able to completely inhibit Bd growth at any 
concentration. Therefore, no MIC values were generated to compare with peptides 
 
 
52 
 
analyzed by other studies. Interestingly, the peptide sample that demonstrated the most 
growth inhibition, allowing only 57% Bd growth at 500 µg/mL, came from the susceptible 
species, G. nebulanastes (Figure 6). Similarly, the susceptible Rana muscosa has been 
shown to have more potent anti-Bd AMPs than resistant congenerics (Woodhams et al., 
2007b, Rollins-Smith et al., 2006). These results suggest that stronger peptides may be 
necessary to provide in vivo protection. However, even peptides capable of complete 
growth inhibition have been produced by susceptible frogs. This has been demonstrated 
in frogs from different families distributed worldwide, including: Alytes obstetricans in 
Europe (Bosch and Rincón, 2008), Silurana tropicalis in Africa (Parker et al., 2002), 
Rana tarahuamara in the United States (Rollins-Smith et al., 2002c), and Hylomantis 
lemur in South America (Conlon et al., 2007b). 
It is difficult to attribute G. excubitor’s chytridiomycosis resistance to AMPs 
because peptide samples from individuals within this species varied in their abilities to 
inhibit Bd growth: some peptide mixtures inhibited Bd growth, but some enhanced it 
(Figures 8 and 9). None of those that inhibited Bd growth were particularly strong 
(Figure 8). One of the strongest inhibiting peptide mixture was collected from the frog 
with the highest Bd load, suggesting that the Bd inhibition demonstrated by the assay 
might not translate to in vivo inhibition.  
The prevalence of Bd reported from this study was low and similar for the 
Gastrotheca species. Historically, prevalence has been consistent for G. nebulanastes 
but has varied for G. excubitor, although overall values were relatively low. No 
individuals from either species tested positive for Bd in 2008 (Catenazzi et al., 2011). In 
2009 prevalence was 25% and 18.2% (Catenazzi et al., 2011) and in 2012 prevalence 
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was 25% and 46.4% (Burkart et al., unpublished) for G. nebulanastes and G. excubitor, 
respectively. Despite the high prevalence for G. excubitor in 2012, individual infection 
levels were generally low for both species (Burkart et al., unpublished). The overall low 
prevalence of Bd infection observed between these species, despite their differences in 
susceptibilities, may be attributed to their similar life history characteristics. Because 
they are direct-developers (Duellman and Maness, 1980), it is unlikely that either utilizes 
bodies of water, where Bd infection typically occurs. This may also explain why G. 
nebulanastes coexists with Bd despite being susceptible to chytridiomycosis.  
Perhaps the difference in susceptibility between these frogs can be attributed to 
another defense mechanism such as anti-Bd skin bacteria. This defense has been 
associated with chytridiomycosis resistance (Woodhams et al., 2007b, Becker and 
Harris, 2010, Park et al., 2014). In a concurrent study we found that G. excubitor has 
more and stronger anti-Bd skin bacteria than G. nebulanastes. Therefore, it is likely that 
bacteria plays a more important role in protecting G. excubitor from Bd than AMPs. 
 
CONCLUSIONS: 
Understanding what protects resistant frog species from chytridiomycosis can 
assist in the development of mitigation strategies. Our results suggest that, at least for 
these marsupial frogs, peptides are not important contributors to chytridiomycosis 
resistance. Perhaps other defenses like cutaneous bacteria are. So far there has been 
some progress made towards developing a bioaugmentation strategy using probiotic 
bacteria to protect susceptible frogs. Although this method is still in development, it has 
been implemented successfully in vitro, and there are currently no proposals to use 
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AMPs as a mitigation strategy. However, it will be important to continue exploring the 
anti-Bd abilities of both of these defenses. Both skin bacteria and AMPs coexist in the 
microbiome of the skin, and it is likely that interactions between the two dictate their anti-
Bd abilities in vivo.  
 
 
55 
 
Table 2: Solutions used for AMP collection. 
____________________________________________________________________ 
Solution   Purpose  Ingredients   Reference 
Norepinephrine Injection  Stimulate the  Norepinephrine, APBS Rollins-Smith  
(40 nmol norepinephrine) release of AMPs     et al. 2005 
 
Amphibian Phosphate Solvent for   6.6 g of NaCl, 1.15 g  Doug  
Buffered Saline (APBS) norepinephrine of anhydrous Na2HPO4,  Woodhams,  
 
       0.2 g of KH2PO4, per 1  pers. comm. 
       liter of ultra-pure (HPLC  
       grade) water 
 
50% HCl buffer  Acidify skin   550 ml of concentrated  Doug  
    washings  HCl, 500 ml HPLC water Woodhams,  
           pers. comm. 
 
Buffer A (0.1% HCl)  Activating Sep Pak  1 ml of concentrated HCl, Doug  
    cartridges  1 liter of HPLC water Woodhams,      
           pers. comm. 
   
Buffer B (70% acetonitrile) Elution of peptides 700 ml of acetonitrile, Louise 
Rollins   from Sep Pak 1 ml of concentrated HCl,  Smith, pers.  
    cartridges  and 300 ml of HPLC comm.  
       grade water 
______________________________________________________________________________________ 
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Table 3: Numbers of Gastrotheca individuals with common peptide signals. The top row 
is G. nebulanastes and the bottom G. excubitor. 
______________________________________________________________________ 
Peptide m/z 
 
1128/1150   1226   1298   1430/1452   1437     1688    1911    2160   2164   3164   3742 
 
6/4         0          6  22/5         0          0          5         5          4         0          5 
 
0/9              9          3          1/0               5        19          0         0          0         7         0  
______________________________________________________________________________________ 
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Figure 5: Mean, quartiles, and range of peptide mixture amounts recovered for all 
individuals (dots indicate outliers). 
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Figure 6: Mean + 490, as a function of peptide mixture 
concentration (500-3.125 µg/mL), for peptide mixtures of G. nebulanastes that inhibited 
Bd. N indicates negative control and P positive control. Each panel (A-D) represents the 
results from an indivual peptide sample. 
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Figure 7: 490 (mean + SE), as a function of peptide mixture 
concentration (500-3.125 µg/mL), for samples from G. nebulanastes that did not inhibit 
Bd. N indicates negative control and P positive control. Each panel (A-D) represents the 
result from an individual peptide sample.   
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Figure 8: Mean + 490, as a function of peptide mixture 
concentration (500-3.125 µg/mL), for peptide mixtures of G. excubitor that inhibited Bd. 
N indicates negative control and P positive control. Each panel (A-E) represents the 
results from an indivual peptide sample.  
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Figure 9: Mean + 490, as a function of peptide mixture 
concentration (500-3.125 µg/mL), for peptide mixtures of G. excubitor that did not inhibit 
Bd. N indicates negative control and P positive control. Each panel (A-D) represents the 
results from an indivual peptide sample. 
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Figure 10: The split plot design of the Bd growth inhibition assays. Level 1 is species, 
Level 2 individuals sampled (n=8 for G. nebulanastes and n=9 for G. excubitor), and 
Level 3 are the different peptide concentrations tested. There were five replicates of 
every concentration for each individual, but replicates were average for analysis.  
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Figure 11: Growth for each sample assayed (mean of the five replicates) per peptide 
concentration. Blue indicates values for G. nebulanastes and orange values for G. 
excubitor.   
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